Trastuzumab Terminated Phase 3 Trials for Cancer, Breast / Metastasis / Sur-expressing Her2-neu Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00625898BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
NCT01613482TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention
NCT00440622Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients